AI accelerates biopharma from discovery to production, cutting cycle times by up to 40%.
Tevogen.AI has successfully developed the alpha version of its PredicTcell™ model, which significantly accelerates target analysis in drug discovery, potentially saving billions in healthcare costs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results